Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Daniel Tasse > Profile

Daniel Tasse

Affiliations

  • at Regenxbio Inc. (RGNX), 2025-06-03
  • Chief Executive Officer at Dbv Technologies S.a. (DBVT), 2024-12-05
  • Director at Bellerophon Therapeutics Inc. (BLPH), 2018-06-25
  • Interim Pres-Hospital Business at Mallinckrodt Plc (MNK), 2015-05-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DBVT $0.83 17,094 $14,188.02 17,094 2024-03-08 Filing
BLPH $12.00 25,000 $300,000.00 128,898 2015-02-19 Filing